NEW YORK (GenomeWeb) – NeoGenomics and Definiens announced today that they have expanded their cancer biomarker discovery alliance to include the development and automation of assays for clinical trials and clinical testing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.